(120 days)
No
The summary describes a mechanical endoscopic surgical system and does not mention any AI or ML components or capabilities.
Yes
The device is indicated for carpal tunnel release and cubital tunnel release, which are therapeutic procedures.
No
Explanation: The device is described as a surgical system for minimally invasive ligament or fascia release (surgical treatment), not for diagnosing conditions.
No
The device description explicitly lists multiple hardware components including an endoscope, handpiece, blade assemblies, sterilization tray, and manual surgical instruments.
Based on the provided information, the MicroAire SMARTRELEASE® Endoscopic Soft Tissue Release System is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The MicroAire SMARTRELEASE® system is a surgical device used during a surgical procedure to physically release ligaments or fascia within the body. It is a tool used by a surgeon to perform a physical action on the patient's tissues.
- Lack of Sample Analysis: The description does not mention the device analyzing any samples taken from the patient's body. Its function is mechanical and visual (via the endoscope).
Therefore, the device falls under the category of a surgical instrument or system, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The MicroAire SMARTRELEASE® Endoscopic Soft Tissue Release System is indicated for use in minimally invasive ligament or fascia release:
- Carpal tunnel release in the wrist
- Cubital tunnel release in the elbow
Product codes
HRX, KCT, EMF
Device Description
MicroAire's SMARTRELEASE® Endoscopic Soft Tissue Release System is comprised of four (4) components: The SMARTRELEASE® Endoscope, the SMARTRELEASE® Handpiece, the SMARTRELEASE® Standard and Low Profile Blade Assemblies and the SMARTRELEASE® Sterilization Tray. In addition, the system includes a set of FDA Class 1 Manual Surgical Instruments. The SMARTRELEASE® Handpiece, the SMARTRELEASE® Endoscope, and the Manual Surgical Instruments are re-usable after cleaning and subsequent sterilization in the SMARTRELEASE® Sterilization Tray. The SMARTRELEASE® Blade Assemblies are gamma sterilized, single-use devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
wrist, elbow
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The following functional testing was performed to verify the following basic functions of the Handpiece and Blade Assembly: Blade Assembly Actuation, Horizontal and Vertical Deflection, Blade Sharpness and Blade Piercing. The system was also evaluated by multiple surgeons per the instructions for use during a cadaver study. All test results demonstrated the MicroAire SMARTRELEASE Soft Tissue Release System can perform it's intended use safely and effectively.
In addition, the SMARTRELEASE® Endoscopic Soft Tissue Release System passed package and distribution testing and applicable biocompatibility testing.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.1100 Arthroscope.
(a)
Identification. An arthroscope is an electrically powered endoscope intended to make visible the interior of a joint. The arthroscope and accessories also is intended to perform surgery within a joint.(b)
Classification. (1) Class II (performance standards).(2) Class I for the following manual arthroscopic instruments: cannulas, currettes, drill guides, forceps, gouges, graspers, knives, obturators, osteotomes, probes, punches, rasps, retractors, rongeurs, suture passers, suture knotpushers, suture punches, switching rods, and trocars. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 888.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the FDA logo is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 6, 2018
MicroAire Surgical Instruments LLC % Ms. Vikki O'Connor Regulatory Affairs Consultant Ambriel Associates, Inc. 411 Walnut St. Unit 9236 Green Cove Springs, Florida 32043
Re: K181819
Trade/Device Name: SMARTRELEASE Endoscopic Soft Tissue Release System Regulation Number: 21 CFR 888.1100 Regulation Name: Arthroscope Regulatory Class: Class II Product Code: HRX, KCT, EMF Dated: October 4, 2018 Received: October 5, 2018
Dear Ms. O'Connor:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Long H. Chen - Digitally signed by Long H.
Chen - Chen - Chen -s Date: 2018.11.06 08:16:55 S -05'00'
for
Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
510(k) Number (if known) K181819
Device Name
MicroAire SMARTRELEASE® Endoscopic Soft Tissue Release System
Indications for Use (Describe)
The MicroAire SMARTRELEASE® Endoscopic Soft Tissue Release System is indicated for use in minimally invasive ligament or fascia release:
- · Carpal tunnel release in the wrist
- Cubital tunnel release in the elbow
| Type of Use (Select one or both, as applicable) | |
|---|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary: MicroAire SMARTRELEASE®
Endoscopic Soft Tissue Release System
In accordance with Title 21 of the Code of Federal Regulations, Part 807, and in particular, 21 CFR Part 807.92, the following summary of information is provided:
| Submitter: | MicroAire® Surgical Instruments Inc. |
|---|---|
| 3590 Grand Forks Blvd. | |
| Charlottesville, VA 22911 USA | |
| Contact Person | Vikki M. O'Connor |
| Regulatory Consultant | |
| Phone : 207-214-8535 | |
| Email : vikki0730@yahoo.com | |
| Correspondance | Mr. Glenn Gerstenfeld |
| Vice President, QA/RA and Compliance Officer | |
| Phone: 434-975-8344 | |
| FAX: 434-975-4144 | |
| Email: glenn.gerstenfeld@microaire.com | |
| Date Prepared | November 5, 2018 |
| Trade Name | MicroAire SMARTRELEASE® Endoscopic Soft Tissue |
| Release System | |
| Proposed Class | Class II |
| Classification Name | Diagnostic Devices - Arthroscope, 21 CFR 888.1100, |
| and Number | Class II |
| Sterilization Container, 21 CFR 880.6580, Class II | |
| Manual Surgical Instrument, 21 CFR 878.4800, Class I | |
| Product Code | HRX, KCT, EMF |
| Predicate Devices | Deployment Handle and Blade Assembly Primary |
| Predicate – A.M. Surgical Mountable Endoscopic Blade - | |
| K080133 (Class I), A.M. Surgical STRATOS® Endoscopic | |
| Release System – Carpal and Cubital Tunnel Release | |
| (Class I, no 510k). Reference: 3M Carpal Tunnel System - | |
| K881703 (Class II) Carpal Tunnel Release. | |
| Arthroscope Primary Predicate - Henke Sass Wolfe | |
| Arthroscope: K080560 (Class II); | |
| Sterilization Tray Primary Predicate - Paragon Medical | |
| Inc. Surgical Instrument Delivery System: K032119 (Class | |
| II); | |
| Device Description | MicroAire's SMARTRELEASE® Endoscopic Soft Tissue |
| Release System is comprised of four (4) components: The | |
| SMARTRELEASE® Endoscope, the SMARTRELEASE® | |
| Handpiece, the SMARTRELEASE® Standard and Low | |
| Profile Blade Assemblies and the SMARTRELEASE® | |
| Sterilization Tray. In addition, the system includes a set of | |
| FDA Class 1 Manual Surgical Instruments. The | |
| SMARTRELEASE® Handpiece, the SMARTRELEASE® | |
| Endoscope, and the Manual Surgical Instruments are re- | |
| usable after cleaning and subsequent sterilization in the | |
| SMARTRELEASE® Sterilization Tray. The | |
| SMARTRELEASE® Blade Assemblies are gamma | |
| sterilized, single-use devices. | |
| Intended Use | The MicroAire® SMARTRELEASE® Endoscopic Soft |
| Tissue Release System is indicated for use in minimally | |
| invasive ligament or fascia release: | |
| • Carpal tunnel release in the wrist | |
| • Cubital tunnel release in the elbow | |
| Subject Device | |
| Summary of the | |
| Technological | |
| Characteristics | The SMARTRELEASE® Endoscope is a standard |
| endoscope used in endoscopic / arthroscopic surgery. It | |
| connects to any standard C-mount video camera system | |
| for visualization and has a light post and two Light Post | |
| Adapters that attach to six of the most common light | |
| sources. There is no electrical source and the endoscope | |
| is re-usable after cleaning and heat sterilization. |
The SMARTRELEASE® Handpiece has a pistol grip and
trigger to facilitate raising and retracting the surgical blade.
The SMARTRELEASE® Blade Assembly is designed to
cut the carpal tunnel ligament or fascia release in the
cubital tunnel with one retracting cut.
The SMARTRELEASE® Sterilization Tray is large enough,
and segmented, to hold and heat sterilize all devices and
instruments required to perform a carpal or cubital tunnel
surgery. The sterilization tray meets the requirements set
forth in ANSI AAMI ST 77:2003. |
| Comparison to
Predicate(s) | The SMARTRELEASE® Endoscope is made by contract
manufacturer Henke Sass Wolf and is identical to the
Henke Sass Wolf Arthroscope (K080560). This is the same
arthroscope used in the 3M Carpal Tunnel System.
MicroAire's SMARTRELEASE® Handpiece and Blade
Assembly is similar in technology, materials and design to
the predicates. The subject and predicate devices all
provide technology to access the wrist or elbow to release
the ligament or fascia during carpal or cubital tunnel
surgery. The Handpieces are made of similar materials,
hold the Blade Assembly and can deploy the blade to
make a cut and retract the blade for removal of the device
from the surgical area(s). The blades are made of 300/400
series stainless steel and are sharp enough to cut fascia / |
| | ligament and are biocompatible. |
| | The subject and predicate tray are made from 300 Series
Stainless Steel and hold all devices that require re-
sterilization. The subject sterilization tray includes a silicon
mat. |
| Summary of
Supporting Data | The following functional testing was performed to verify the
following basic functions of the Handpiece and Blade
Assembly: Blade Assembly Actuation, Horizontal and
Vertical Deflection, Blade Sharpness and Blade Piercing.
The system was also evaluated by multiple surgeons per
the instructions for use during a cadaver study. All test
results demonstrated the MicroAire SMARTRELEASE Soft
Tissue Release System can perform it's intended use
safely and effectively.
In addition, the SMARTRELEASE® Endoscopic Soft
Tissue Release System passed package and distribution
testing and applicable biocompatibility testing. |
4
5
6
7
Summary / Conclusion
MicroAire's SMARTRELEASE® Endoscopic Release System is comprised of the SMARTRELEASE® Handpiece and SMARTRELEASE® Blade Assembly(s) which are FDA Class I Manual Surgical Instruments. The addition of the dedicated SMARTRELEASE® Endoscope to the system and a Sterilization Tray for re-sterilizing the Endoscope, Handpiece and Class I instruments make the overall system a Class II device.
Basic device functional tests and a cadaveric study by multiple surgeons were performed to evaluate the system for the intended use. All test results demonstrated the MicroAire SMARTRELEASE Soft Tissue Release System can perform the intended use safely and effectively.